MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-14-2026
ICON Public Limited Company Current Ratio 2011-2026 | ICLR
Annual Current Ratio ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.29 | 2.19 | 1.98 | 1.87 | 2.17 | 2.33 | 2.35 | 2.25 | 1.94 | 1.51 | 1.52 | 1.7 | 1.61 | 1.83 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.35 | 1.51 | 1.97 |
Quarterly Current Ratio ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.89 | 1.87 | 1.82 | 2.3 | 2.26 | 2.17 | 2.26 | 2.23 | 2.14 | 2.33 | 2.27 | 2.28 | 2.2 | 2.35 | 2.35 | 2.32 | 2.19 | 2.25 | 2.22 | 2.18 | 2.04 | 2.07 | - | - | - | 1.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.35 | 1.8 | 2.16 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
1.27 | $ 15.54 | 5.79 % | $ 2.02 B |  USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.16 | 1.41 % | $ 4.96 M | USA |
 |
Bioventus
BVS
|
1.5 | $ 9.15 | 1.67 % | $ 610 M | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 16.34 | 0.06 % | $ 494 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 83.59 | -1.54 % | $ 10.5 B | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
1.92 | $ 570.21 | -1.43 % | $ 45.9 B | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 74.24 | -1.97 % | $ 5.01 B | USA |
 |
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 460.74 | 0.83 % | $ 13.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
0.994 | $ 1 264.46 | 1.94 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.61 | -1.07 % | $ 427 M | USA |
 |
National Research Corporation
NRC
|
1.12 | $ 17.44 | -0.4 % | $ 390 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
2.02 | $ 194.52 | -2.78 % | $ 19.1 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 159.19 | 0.75 % | $ 7.89 B | USA |
 |
IQVIA Holdings
IQV
|
1.28 | $ 166.09 | -0.52 % | $ 28.6 B | USA |
 |
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
1.01 | $ 1.39 | - | $ 417 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.18 | -19.18 % | $ 6.43 M | USA |
 |
Interpace Biosciences
IDXG
|
0.87 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 125.98 | 1.77 % | $ 20 B | USA |
 |
Personalis
PSNL
|
4.02 | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
4.93 | $ 26.6 | -1.23 % | $ 34.5 M | USA |
 |
RadNet
RDNT
|
1.56 | $ 59.87 | -3.03 % | $ 4.5 B | USA |
 |
Celcuity
CELC
|
1.89 | $ 102.01 | -4.44 % | $ 4.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 266.12 | 0.64 % | $ 22.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
2.35 | $ 3.46 | -0.57 % | $ 1.86 M | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 7.86 | -2.96 % | $ 1.01 B | USA |
 |
Renalytix AI plc
RNLX
|
0.504 | - | 5.66 % | $ 22.7 M | Britain |